Cochlear implant use following neonatal deafness influences the cochleotopic organization of the primary auditory cortex in cats
✍ Scribed by James B. Fallon; Dexter R.F. Irvine; Robert K. Shepherd
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 910 KB
- Volume
- 512
- Category
- Article
- ISSN
- 0021-9967
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Electrical stimulation of spiral ganglion neurons in a deafened cochlea, via a cochlear implant, provides a means of investigating the effects of the removal and subsequent restoration of afferent input on the functional organization of the primary auditory cortex (AI). We neonatally deafened 17 cats before the onset of hearing, thereby abolishing virtually all afferent input from the auditory periphery. In seven animals the auditory pathway was chronically reactivated with environmentally derived electrical stimuli presented via a multichannel intracochlear electrode array implanted at 8 weeks of age. Electrical stimulation was provided by a clinical cochlear implant that was used continuously for periods of up to 7 months. In 10 long‐term deafened cats and three age‐matched normal‐hearing controls, an intracochlear electrode array was implanted immediately prior to cortical recording. We recorded from a total of 812 single unit and multiunit clusters in AI of all cats as adults using a combination of single tungsten and multichannel silicon electrode arrays. The absence of afferent activity in the long‐term deafened animals had little effect on the basic response properties of AI neurons but resulted in complete loss of the normal cochleotopic organization of AI. This effect was almost completely reversed by chronic reactivation of the auditory pathway via the cochlear implant. We hypothesize that maintenance or reestablishment of a cochleotopically organized AI by activation of a restricted sector of the cochlea, as demonstrated in the present study, contributes to the remarkable clinical performance observed among human patients implanted at a young age. J. Comp. Neurol. 512:101–114, 2009. © 2008 Wiley‐Liss, Inc.